Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration ‐resistant prostate cancer treated with Radium‐223

ConclusionsPre-treatment ALB, ALP, ECOG, and PSA, were significantly correlated with OS and could guide treatment selection for men with mCRPC by identifying those who are most or least likely to benefit from223Ra. Validation in an independent dataset is required prior to widespread clinical utilization.

Source: Cancer Medicine - July 13, 2021 Category: Cancer & Oncology Authors: Esmail M. Al ‐Ezzi, Husam A. Alqaisi, Marco A. J. Iafolla, Lisa Wang, Srikala S. Sridhar, Adrian G. Sacher, Nazanin Fallah‐Rad, Di M. Jiang, Geoffrey A. Watson, Charles N. Catton, Padraig R. Warde, Rob J. Hamilton, Neil E. Fleshner, Alexa Tags: RESEARCH ARTICLE Source Type: research